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Cryptosporidium, a protozoan parasite in the phylum Apicomplexa, is the etiological
agent of cryptosporidiosis, an intestinal infection characterized by profuse watery
diarrhea. Over 30 species of Cryptosporidium are recognized, some host specific
whereas others infect a broader host range. Cryptosporidium hominis and
Cryptosporidium parvum are the species most commonly associated with human
infection; C. hominis is largely associated only with human infections, but C. parvum
is also associated with infection in animals, especially young ruminants. In some
regions, cryptosporidiosis is a serious veterinary problem, particularly for calves, and
lambs. Many outbreaks of human cryptosporidiosis have been associated with zoonotic
transmission following contact with infected animals. In Africa, where cryptosporidiosis is
a major contributor to pediatric morbidity and mortality, evidence suggests transmission
is principally anthroponotic. Given the frequent close contact between humans and
animals in Africa, the apparent predominance of human-to-human transmission is
both interesting and puzzling. In this article, after a brief “text book” introduction to
the parasite, we consider in separate sections the different aspects of relevance to
Cryptosporidium transmission in African countries, describing different aspects of the
various species and subtypes in human and animal infections, considering livestock
management practices in different African countries, and looking for any characteristic
“hot spots” where zoonotic transmission has apparently occurred. Studies where
transmission networks have been investigated are particularly relevant. Finally, in a
separate section, we try to gather these different strands of evidence together in order to
assess the reasons behind the apparent predominance of anthroponotic transmission in
Africa. Reviewing the available evidence provides an opportunity to re-think transmission
pathways, not only in Africa but also elsewhere, and also to pose questions. Does
the predominance of human-to-human transmission in Africa reflect a relative absence
of zoonotic C. parvum in African livestock? Are Africans less susceptible to zoonotic
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Cryptosporidium infection, perhaps resulting from early immunostimulation byC. hominis
or due to inherent genetic traits? Is the African environment—in all its variety—simply
more detrimental to oocyst survival? Will the so-called hypertransmissible subtypes,
currently relatively rare in Africa, be introduced from Europe or elsewhere, and, if so,
will they fade out or establish and spread? Our intention with this manuscript is not only
to summarize and consolidate diverse data, thereby providing an overview of data gaps,
but also to provide food for thought regarding transmission of a parasite that continues
to have a considerable impact on both human and animal health.
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INTRODUCTION
Addressing the Zoonotic Transmission
Enigma
When Cryptosporidium was first discovered it was considered
primarily as a parasite of animals, with the first human cases
not identified until some 70 years later. The importance of
Cryptosporidium as a pathogen was first really understood in
the subsequent decade, and, at this time, transmission was
considered to be largely zoonotic. Anthroponotic transmission
was soon recognized, and, with the advent of more precise
molecular tools, it became clear that there was a multiplicity of
species and genotypes with different host-specificities. However,
despite frequently being described as “ubiquitous,” there are
clearly geographical differences in the distribution of species,
genotypes, and transmission routes. We are now more acutely
aware of the global disease burden due to cryptosporidiosis, with
the brunt of that burden borne by young children in African
countries. At the same time, we have the enigma that, despite
the closer relationship between people and animals in African
countries compared with more industrialized countries, zoonotic
transmission seems to occur less frequently in Africa (and some
other regions) than in more developed regions, such as Europe.
In this article we explore this further, first giving a general
introduction to the parasite itself, then providing a background
on the parasite as a zoonosis and some background information
on the burden from cryptosporidiosis in Africa, concerning
both human and animal health. An overview of the species
and subtypes of Cryptosporidium identified in infections in
African countries is provided based on published papers,
and also current perspectives on the potential for waterborne
transmission. It should be noted, however, that identification of
species and subtypes of Cryptosporidium is reliant on molecular
techniques, which, in turn, require a relatively sophisticated
laboratory with steady electricity supply and reagents that
must be transported, and stored, frozen. In many parts of
Africa, the infrastructure for molecular characterization is
not yet developed and this means that our insights are,
likewise, patchy.
We then consider animal husbandry in African countries, with
emphasis on cattle, the species most associated with zoonotic
transmission elsewhere. We tie this to an overview of those
places and situations in Africa where zoonotic transmission has
apparently occurred and try to identify defining characteristics.
Finally, we extract from the previous sections those issues that are
relevant regarding possible reasons why zoonotic transmission
may occur less frequently in African countries than elsewhere,
and compare and discuss their likely effects on transmission
routes. In addition, we discuss whether, on both a global basis and
from the African perspective, there is likely to be a shift toward an
increase or decrease in zoonotic and anthroponotic transmission.
General Introduction to Cryptosporidium
and Cryptosporidiosis
Cryptosporidium is a unicellular parasitic protozoan in the
phylum Apicomplexa. Although considered a member of
coccidia, evidence indicates that it has a closer affinity with
gregarines, a large group of Apicomplexa considered particularly
primitive (1). This classification has implications for the survival
and spread of this parasite. To date, over 30 species of
Cryptosporidium have been identified, some of which are host
specific, whereas others are more promiscuous regarding host
infectivity. Furthermore, whereas infection with some species
of Cryptosporidium tend to be associated with little or no
illness, others are particularly pathogenic with severe symptoms,
which may even result in mortality. However, whether infection
manifests as disease (cryptosporidiosis), and the severity of that
disease, also depends on host factors, particularly those associated
with host immunity and other health challenges.
Cryptosporidiosis usually manifests as a gastrointestinal
disease, with diarrhea the most common clinical presentation.
The lifecycle is predominantly fecal-oral, although often indirect
with transmission by a vehicle such as water or food (see
Figure 1). Although this article focuses on gastrointestinal
infection, it should be mentioned that, for some Cryptosporidium
species and hosts, respiratory cryptosporidiosis is also relevant.
The oocyst transmission stage, which is infectious upon excretion
without any requirement for maturation in the environment,
is very robust and can be shed in high quantities, both
characteristics that facilitate transmission via environmental
contamination. When an infective oocyst is ingested it excysts
in the small intestine and the released sporozoites invade the
epithelial cells, where, in an epicellular location (intracellular
but extracytoplasmic), asexual multiplication occurs. The
resulting merozoites invade neighboring cells, and sexual
multiplication occurs with the production of microgamonts and
macrogamonts; following fertilization of the macrogamonts,
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FIGURE 1 | Transmission routes of Cryptosporidium spp. [from (2), copyright European Food Safety Authority].
oocysts are produced that sporulate within the host before being
shed in host feces.
The pathogenesis of cryptosporidiosis is associated with
damage and changes to the cells of the intestinal wall; the
interaction of Cryptosporidium sporozoites and merozoites with
host cells results in signaling cascades with molecules (such
as proteases and hemolysins) damaging cells, increasing fluid
secretion, and causing malabsorption. Although usually self-
limiting in the immunologically robust host, post-infection
sequelae have been reported in human cases, although may
reflect host immune responses or gut dysbiosis, rather than
infection per se.
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Cryptosporidiumwas first identified as an infection of animals,
with human infections not reported until the mid-1970s. Even
by 1980 only a handful of human cases had been reported, and,
as a primary cause of acute diarrheal disease, it was largely
unrecognized until the global HIV pandemic emerged, when
Cryptosporidium became one of the first defining entities of
AIDS. At this point, the potential for large communitywide
outbreaks of waterborne cryptosporidiosis was also recognized,
with various sizeable waterborne outbreaks documented.
For many years, only a single species, C. parvum, was
really noted as the cause of human cryptosporidiosis, with C.
hominis not recognized as a separate species until 2002 (3).
Among the 30 or so Cryptosporidium species now identified,
C. parvum is considered of substantial veterinary relevance to
young livestock (calves and lambs), being considered as one of the
most important causes of neonatal enteritis in young ruminants
globally (4), and is also considered of major importance as a
zoonotic species. Other zoonotic species include C. meleagridis
(also commonly found in poultry), C. cuniculus (found in
rabbits), and C. ubiquitum (commonly found in sheep); C.
hominis largely infects humans. Other species are also generally
host specific.
In people, where most infections are caused by C. hominis
and C. parvum, the disease is generally acute and self-limiting,
with symptom onset within about a week, and causes prolonged
or persistent diarrheal episodes more often than other enteric
pathogens. However, as treatment options are limited (the
only FDA licensed treatment, nitazoxanide, licensed for treating
patients aged 1-year and older, is only considered effective in
those with healthy immune systems), it can be a serious illness
in the very young, malnourished, and immunocompromised.
In low-income countries, cryptosporidiosis is a major cause of
infectious-disease mortality in children below 2 years (5).
We are now well aware of the multiplicity of species
of Cryptosporidium and, in particular, the two main species
infecting humans and the important differences in their
epidemiology and transmission routes. As oocysts of C. hominis
and C. parvum (and of most other zoonotic species) are
morphologically identical, determining the infecting species
relies on use of molecular tools. Such techniques are now used
in many studies to determine species, and, often, subtypes,
in Cryptosporidium infections, both in humans and animals,
and have provided some insights into distributions and risk
factors. However, many publications, even recent, refer to human
Cryptosporidium infection as being with C. parvum, even when
the species has not actually been determined. In many African
countries, the infrastructure and trained personnel for such
molecular analyses to determine species are not yet in place and
this is reflected in the information available.
Cryptosporidium As a Zoonotic Agent: A
Historical Perspective on Species and
Genotypes
As noted, the first infections with Cryptosporidium were
identified in animals, and many subsequent reports in the
early 1980s concentrated on infections in various animals, with
particular emphasis on livestock and rodents. The two first
recorded human cases of cryptosporidiosis were from people
living on farms (6, 7), and although the likelihood that cattle
may have been the infection source was not raised, these cases
strengthened the supposition that cryptosporidiosis is primarily
an animal infection, with zoonotic potential.
Although cross-infection studies from Cryptosporidium
isolates from guinea pigs failed to infect other animal species (8),
further cross-infection studies with isolates from calves resulted
in infections being established in lambs, calves, pigs, rats, mice,
guinea pigs, and chicks (9). The latter authors suggested that
their success with cross-infection studies, compared with the
lack of success of Vetterling et al. (8), reflected that in their own
experiments the challenged hosts were less than 1-day old and
specific-pathogen free. Based on their results, they went so far as
to propose that Cryptosporidium could be a single-species genus,
much like Toxoplasma gondii (9). In retrospect, it is easy for us
to see that this confusion arose due to the latter cross-infection
studies using C. parvum, and the first cross-infection studies
using a host-specific Cryptosporidium species (presumably
C. wrairi). However, further experimental infection studies
also supported the hypothesis that Cryptosporidium lacks host
specificity and should therefore be regarded as a potential
zoonosis (10). The first description of cryptosporidiosis in a
veterinary student was published in the same year (11) and has
been followed by at least a dozen more such reports since then.
Although a review of the taxonomy of Cryptosporidium in
1984, did not support the view of a single species, it concluded
that although 19 species had been named at that time, only 4
should be considered valid: C. muris in mammals, C. meleagridis
in birds, C. crotali in reptiles, and C. nasorum in fish (12). One
year later, C. parvum was proposed to be the Cryptosporidium
species infecting most mammals, including humans, distinct
from C. muris for which the reported oocyst size was larger
(which Levine had apparently overlooked) (13).
Although cryptosporidiosis as a zoonosis was rapidly
accepted, at around the same time various studies reported that
not all human infections were associated with animal contact.
A study in a British children’s hospital noted that most patients
infected with Cryptosporidium did not have a history of close
animal contact, suggesting that person-to-person transmission
was as important as zoonotic transmission (14). Similarly, a
UK survey of patients with gastrointestinal symptoms found
that of the 5% with cryptosporidiosis, contact with animals
was not a feature (15). Indeed, an extensive long-term study
from Wales (16), culminated with the authors concluding
that although animals may be a source of Cryptosporidium
infection in people, human-to-human infection probably occurs
more commonly, and cryptosporidiosis should not be regarded
primarily as a zoonosis.
Most of these first epidemiological studies exploring
Cryptosporidium infections, uncovering evidence of both
zoonotic and anthroponotic transmission, are from
industrialized countries, particularly Europe and North
America. However, among these earlier reports are two from
Liberia that describe associations of Cryptosporidium infections
in children under 5-years of age with a range of different
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factors (17, 18). As with the reports from UK (15, 16), the
authors of the Liberian study concluded by questioning the
general belief of that time, that cryptosporidiosis is primarily
a zoonosis. They grounded their suspicion on their findings
that cryptosporidiosis in Liberian children seemed to occur
in regions where domestic animals were uncommon, was
associated with household crowding and bottle feeding, and that
peak prevalence was among infants still carried on their mothers’
backs and thus not in particularly close contact with animals or
the wider environment (17, 18). Thus, although no suggestion
was made that more than one species of Cryptosporidium may
be involved in gastrointestinal cryptosporidiosis in humans, it
was recognized from studies, including in Africa, that different
epidemiologies could be important, and that there could be a role
for both animal-to-human and human-to-human transmission.
It was not until the late 1980s and early 1990s that evidence
began to mount, based initially on isoenzyme analysis and
thereafter molecular tools, such as PCR-RFLP and sequence
investigation, that, as well as there being an animal-to-human
or a human-to-human cycle of C. parvum infections, there was
also another type of Cryptosporidium that essentially infected
solely humans. These two groups were initially designated as
the zoonotic “cattle” genotype (usually designated genotype II
or sometimes genotype C) and the anthroponotic “human”
genotype (genotype I or genotype H); this latter type of
Cryptosporidium received a formal species designation, C.
hominis, in 2002 (3). It is now well established that not only
are there two species of Cryptosporidium causing most cases
of human cryptosporidiosis, C. parvum with its two potential
cycles of animal-to-human or human-to-human and C. hominis
being almost exclusively human-to-human, but that there are also
subtypes within these species that also seem to have virulence
and host infectivity differences. Indeed, someC. parvum subtypes
(e.g., IIc, IIe, and IIm) are apparently almost exclusively limited to
human infections, despite the species being generally considered
zoonotic. Indeed, C. parvum subtype IIc has recently been
proposed as being classified as an anthroponotic subspecies -
C. parvum anthroponosum (19). Whereas PCR and sequencing
at the SSU rRNA gene is now the most common method for
determining Cryptosporidium species, for determining subtype
within species most reports use sequence variations in part
of the hypervariable 60 kDa glycoprotein (gp60) gene; use of
these markers has been described in several publications [e.g.,
(20–22)]. These molecular tools provide not only a means of
exploring transmission pathways in greater detail, but are also
useful in outbreak investigations; an outbreak of waterborne
cryptosporidiosis in which C. hominis is identified in those
infected will point investigators toward considering sewage
contamination, rather than runoff from agricultural land.
THE IMPACTS OF CRYPTOSPORIDIOSIS
IN AFRICA
Human Health Impacts
There is no doubt that cryptosporidiosis has a substantial health
impact globally, particularly in lower-income countries. Most
African countries are classified using World Bank definitions
(23), as having low-income or lower-middle income economies,
with the exception of Algeria, Botswana, Equatorial Guinea,
Gabon, Libya, Mauritius, Namibia, and South Africa, which are
classified as upper-middle income, and Seychelles being high
income. Of the 31 countries globally classified as being in the
lowest income group, 24 (77%) are in Africa.
One of the earliest studies investigating the impact of
Cryptosporidium in an African country was from Guinea Bissau,
and demonstrated that Cryptosporidium was associated with
excess mortality in children younger than 12 months, with
this excess mortality persisting into the second year of life
(24). Although this impact from cryptosporidiosis in particular
countries has long been assumed, the first comprehensive
data demonstrating this were produced relatively recently,
from the Global Burden of Disease (GBD) and the Global
Enteric Multicenter Study (GEMS) outputs [e.g., (5, 25, 26)
etc.]. These studies provided the first global estimates on
impacts of cryptosporidiosis (among other diseases) in different
age groups and different countries, in terms of mortality,
morbidity, and disability-adjusted life-years (DALYs). A meta-
analysis published in 2018 showed that earlier reports probably
under-estimated the true burden by not taking into account
impacts occurring after the acute phase of infection, such as
decreased growth, particularly weight gain, and a greater risk
of subsequent episodes of infection (27). As Cryptosporidium
diarrhea damages gut endothelial cells and microvilli, absorption
of macronutrients, and micronutrients are impaired (28, 29).
In addition, Cryptosporidium-related malnutrition results in
secondary impairment of cell-mediated immunity, which is
associated with increased susceptibility to other infectious
diseases. Other long-term sequalae include reduced cognitive
development, poor school performance, and elevated risk of
cardiovascular and metabolic diseases later in life (30, 31), all
likely to have a disproportionate effect on the global poor.
Cryptosporidium infection in children under 5 years was
estimated to be associated with 44.8 million diarrheal episodes
and 48,300 deaths globally (27). Of these, the vast majority
were from Africa, accounting for 75% of the diarrheal episodes
and 88% of the deaths (27). In particular, the burden of
Cryptosporidium-associated diarrhea is greatest in Sub-Saharan
Africa, especially Nigeria and the Democratic Republic of the
Congo (DRC) where about 48% of the under-5 associated
deaths occur (27). When including downstream effects of growth
shortfalls associated with cryptosporidiosis, it was estimated that
the burden of this parasite could be 2.5 times higher than
previous estimates (27), and recognized that accounting for
the direct or indirect burden of asymptomatic infections could
elevate these estimates even further.
Veterinary Health Impacts
It is well known that whereas infection with some species of
Cryptosporidium has apparently marginal impact on host health,
ruminants, particularly young animals, infected with C. parvum
may suffer from profuse watery diarrhea, inappetence, lethargy,
and dehydration; it is not unusual for death to occur, particularly
in neonates. With an infectious dose for neonatal calves as low as
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17 oocysts (32), ensuring that young stock are not exposed to an
infectious dose on farms where other stock are already infected
can be challenging. As with humans (see previous subsection),
it has also been shown that severe cryptosporidiosis in calves
and lambs may have long-term consequences regarding growth,
weight gain, and productivity (33–35), as well as the more
immediate effects from the acute infection.
Cryptosporidiosis outbreaks on farms are not commonly
investigated and reported, but have been described among
cattle and goats from farming enterprises in Europe and Asia
[e.g., (36–38)]. Although there are no published reports of
cryptosporidiosis outbreaks among livestock in Africa, several
studies from different African regions have reported on calf
diarrhea without any clear attribution to a specific etiological
agent (39–41). Given that a variety of etiological agents, as
well as Cryptosporidium, can cause calf diarrhea (e.g., rotavirus,
coronavirus, bovine viral diarrhea virus, E. coli, Clostridium
perfringens, Salmonella spp., and coccidia such as Eimeria
zuernii and E. bovis), these data do not necessarily indicate
cryptosporidiosis. A similar situation applies to lambs and
goat kids.
A systematic review of Cryptosporidium infections in livestock
(42) noted the prevalence being highest in the Americas and
Europe—and commented that under-investigation in particular
regions was not the reason for this skewed distribution. However,
publication bias and insufficient information may have excluded
some relevant studies (42). Nevertheless, some researchers report
that Cryptosporidium oocysts are frequently detected in diarrheic
calves in different African countries (43–46), but usually without
determining whether cryptosporidiosis is the cause of the
symptoms. Many of these studies use modified Ziehl-Neelsen
(mZn) for identification; this has low sensitivity and specificity,
and does not enable identification of theCryptosporidium species.
Studies using more accurate tests have revealed contrasting
results; for example, a study from Tanzania used, in addition
to mZn, immunofluorescent antibody testing (IFAT), auramine
phenol staining, and molecular methods to investigate calves
for Cryptosporidium infection and, using the latter methods,
did not detect Cryptosporidium shedding in 943 calf samples,
of which over 6% were diarrheic, despite some positive results
with mZn (47). The authors suggest that data obtained using
mZn should be treated with caution. In contrast, a study in
Egypt using molecular tools reported a 32% Cryptosporidium
prevalence in cattle (48). Two studies from Ethiopia, both of
which used molecular methods for determining infecting species,
provide contrasting data: a study from two large dairy farms
in central Ethiopia showed that Cryptosporidium infection was
common (40% cumulative incidence), with C. parvum most
common in pre-weaned calves and C. andersoni in post-weaned
calves (49). In contrast, an earlier study in an overlapping area,
included 449 calves from both smallholder farmers and dairy
farms and detected less than 10% infection, with C. andersoni,
C. bovis, and C. ryanae identified, but not C. parvum (50). It is
noteworthy that whereas the first two studies (48, 49) associated
Cryptosporidium infection with a calf-health impact, the latter
(50) reported that the calves were generally healthy, with only a
few cases of watery diarrhea.
CRYPTOSPORIDIUM INFECTIONS IN
AFRICA: DISTRIBUTIONS OF SPECIES/
GENOTYPES
Two reviews of Cryptosporidium in Africa were published
relatively recently (51, 52), the latter of which also considers
Giardia. Although these articles have slightly different
overall perspectives, both contain information on molecular
epidemiology and have assimilated data from the literature
describing the occurrence of different Cryptosporidium
species/genotypes in various host species in different regions.
Aldeyarbi et al. (51) used a defined literature search to gather
data, but the authors excluded studies considered to be weakly
designed or biased (although how these criteria were determined
is unclear). The conclusion from this review is that both
anthroponotic and zoonotic transmission cycles have potential
for infecting people in Africa, that infections in wild animals
are “essential contributors” to environmental contamination
that threatens human health, but that C. hominis was the
predominant species infecting people in many studies, regardless
of host immune status (51). In addition, the authors noted that
among human C. parvum infections in various sub-Saharan
African countries, the GP60-subtype family IIc [previously
Ic, proposed now as C. parvum anthroponosum; (19)] often
predominates. As noted, this is a human-adapted subtype
occurring almost exclusively in human infections. A recent
systematic review and meta-analysis investigating geographical
distribution of this subtype in human infections (53) found its
occurrence was associated with countries with low GDP per
capita and poor sanitation; of 81 relevant single-country articles
included in their study (20 from Asia, 20 from Africa, 21 from
Europe, 7 from North America, 3 from South America, 10 from
Australia/Oceania), 35 reported the presence of C. parvum IIc
subtype (C. p. anthroponosum), of which 14 were from Africa
(53). Thus, we can extrapolate a significant association between
this particular subtype and Africa, as compared with the rest of
the world combined (p < 0.0086). Furthermore, the proportion
of this subtype among C. parvum isolates in those studies
reporting its presence was also higher in Africa (2–100%; mean
75%, median 76%) compared with the rest of the world (3–100%;
mean 36%, median 22%).
In a study based on the GEMS data, but looking specifically
children younger than 2 years, in some regions of sub-Saharan
Africa and south Asia, of 28 C. parvum infections fromMali (n=
13), Kenya (n = 9), Mozambique (n = 5), and Gambia (n = 1),
all were anthroponotic IIc or IIe (54). In industrialized countries,
subtype IIaA15G2R1 predominates among both dairy cattle and
human C. parvum infections, and is sometimes described as
hypertransmissible (55, 56). However, in Africa, this subtype has
been reported from both cattle and humans in only two countries,
Egypt and Tunisia, and also in people in Nigeria—indicating
that it does not (yet) predominate here. Thus, despite presently
predominating in some circumstances and regions, whether it
always or intrinsically transmits more successfully has not been
clearly demonstrated.
A relatively high frequency of C. meleagridis infections has
been reported in African studies, as mentioned by Aldeyarbi
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et al. (51) (of the studies considered, the authors report C.
meleagridis among 21% of the immunocompromised and 10%
of non-immunocompromised people, compared with below 1%
in the developed world). Although C. meleagridis is also a
zoonotic Cryptosporidium species, many of the papers from
Africa do not indicate an association with infected animals
or birds [although an association with chicken C. meleagridis
infections has been suggested in Côte d’Ivoire (57) and Nigeria
(58)] and some actually indicate a lack of association with chicken
infections [e.g., (59)], perhaps suggesting transmission from a
human source.
The more-recent review paper (52) tabulates Cryptosporidium
infections in papers from African countries published from
2010 to 2016 according to prevalence (occurrence) in human
cohorts (along with information on diagnostic technique),
and by Cryptosporidium species and genotype according to
patient group. Similar data for animal hosts, both wildlife
and domestic animals, are tabulated separately. This is a
comprehensive undertaking (although data published separately
from the same research studies are sometimes listed twice),
and, similarly to Aldeyarbi et al. (51), the authors note the
predominance of anthroponotic transmission, with C. hominis
and anthroponotically transmitted C. parvum being reported
principally in human infections.
Using a literature survey of PubMed (using the search terms
of each African country in turn along with Boolean AND and
cryptosporidi∗) we identified a further 45 papers not included in
the Squire and Ryan (52) review, 34 of which had been published
from 2017 and onwards (Figures 2, 3). Of these additional
articles, 17 involved Cryptosporidium in human hosts only, 19
involved animal hosts only, and 9 considered both human and
animal hosts. One article was from the Gambia (60), a country
not featuring in the Squire and Ryan (52) review. This article
reported more closely on Cryptosporidium infections in children
enrolled in the GEMS study, and, although most (>80%) were
C. hominis, a significant association with animals (cats or cows)
living in the compound was also reported (60). However, given
the host specificity of C. hominis, and that these animals were
not themselves tested for infection, the presence of animals in
the compound could be an indicator of another risk factor, rather
than being the infection source.
Of relevance regarding C. hominis infections in Africa, is that
subtype IbA10G2, which is associated with most outbreaks in
industrialized countries (22, 61–63), and has been described as
being hyper-virulent (55, 61, 62), despite evidence for differences
in clinical symptoms or advanced transmission within gp60 allele
families being weak, seems to occur rarely in Africa. It was not
found in a subtyping performed with the GEMS study samples
(54), and has been reported only sporadically in surveys [from 3
children (of 28 with subtyped C. hominis) in Nigeria (64); from 1
HIV/AIDS patient (of 19 with subtyped C. hominis) in Ethiopia
(65); a maximum of 2 children (of 19 with subtyped C. hominis)
in South Africa (66); and 1 HIV and TB patient (of 2 typed with
C. hominis) in Mozambique (67)].
Among the 32 articles investigating Cryptosporidium in
animals in Africa included by Squire and Ryan (52), 16 (50%)
reported on cattle and 4 reported on sheep or goats; in the
additional articles that we identified, 8 reported on cattle and
7 on sheep and/or goats. These articles do not indicate any
clear patterns regarding infectious species or subtypes, although
one with data from cattle reported the presence of the “hyper-
transmissible” IIaA15G2R1 subtype (68); however, as reported
from other global regions, the data indicate that younger animals
(both calves, lambs, and goat kids) seem more likely to be
infected with C. parvum than older animals (69). Nevertheless,
age does not seem to be the only determinant regarding infection
with zoonotic Cryptosporidium species in cattle husbandry.
For example, a Zambian study investigating the species of
Cryptosporidium in calves demonstrated that whereas calves from
intensive dairy farms and extensive commercial beef farms (mean
calf age 15 and 26 days, respectively) were largely infected with
C. parvum, among calves infected with Cryptosporidium on small
traditional farms (mean calf age 22 days), only C. bovis was
identified (70).
Among small ruminants, the occurrence of C. parvum
infection seems to be rather low in studies from Africa; among
the 6 studies compiled by Squire and Ryan (52), of those
including small ruminants (sheep, goats), only 3 (50%) reported
the presence of C. parvum, with the other studies reporting
only C. xiaoi. Of the more recent papers, a couple with very
low numbers of samples (between 1 and 8 samples) report
C. parvum in sheep and goats [e.g., from Nigeria (58); from
Sudan, (71); from Uganda, (72)]. Larger studies, however,
indicate that C. parvum occurs relatively infrequently in African
small ruminants, with C. xiaoi predominating in sheep and goats
in Ghana (73) and a study in Ethiopia including 389 lambs
under 5 months of age found only C. ubiquitum (74). Although
C. ubiquitum has zoonotic potential (75), human infections in
Africa have been reported only extremely rarely [one study from
Nigeria, with two publications noted by Squire and Ryan, (52)].
Of interest is that the single C. parvum isolate from a goat in
the study from Ghana was typed as being the anthroponotic
IIc subtype (C. p. anthroponosum); with molecular methods
being the only analytical tool used, it is possible that this single
C. parvum infection among 285 goat samples of which 95 were
positive, represents carriage rather than infection. Furthermore,
a comprehensive contact-network analysis study conducted in
4 African countries [Gabon, Ghana, Madagascar, and Tanzania;
(76)], not only reported that C. hominis predominated among
human isolates (from children below 5 years), but also that
C. hominis occurred not infrequently in their animal contacts
(goats, sheep, cows, dogs). However, given that these animals
may well have ingested feces of infected children, it is unclear
whether we can infer zoonotic transmission here rather than
carriage in those animals in which C. hominis DNA was detected
(12 cows, 5 goats, 1 sheep, and 3 dogs), given how rarely
this species has previously been identified in animal infections.
Indeed, the authors themselves emphasize that human-to-human
transmission appears to be the predominant route in their 4 study
sites, with zoonotic transmission contributing only marginally
(76). It is unfortunate that environmental samples were not
analyzed in this study, as this could, potentially, have added even
greater weight to the study findings.
In addition to the two review papers concerned with
Cryptosporidium in Africa (51, 52), a slightly older review
considers Cryptosporidium in the Arab world (77), which
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FIGURE 2 | Map of Africa indicating those countries where human infection with Cryptosporidium has been investigated; articles either referenced in Squire and Ryan
(52) or identified by current literature search.
also includes some countries from Africa (specifically Algeria,
Comoros, Djibouti, Egypt, Libya, Morocco, Mauritania, Somalia,
Sudan, and Tunisia). Although the authors concluded that
zoonotic transmission is important, little supportive molecular
evidence was presented.
WATER AS A CRYPTOSPORIDIUM
TRANSMISSION VEHICLE IN AFRICA AND
POTENTIAL FOR CONTAMINATION
The potential for water to be a transmission vehicle for
Cryptosporidium is accepted globally, with communitywide
outbreaks and smaller outbreaks reported from multiple
countries. The dearth of such outbreaks being reported
from Africa probably represents limitations in technological
capabilities and surveillance systems (78). It must also be
considered that with a high background prevalence of diarrheal
disease (of whatever etiology)—albeit varying regionally (79)—
it is probably more difficult for an outbreak to be identified
in Africa unless extremely dramatic. Even in countries with a
relatively low incidence of diarrheal diseases and well-developed
reporting systems, identifying a cryptosporidiosis outbreak may
not be straightforward; not all cases seek medical attention,
doctors may not request stool samples, and stool samples may
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FIGURE 3 | Map of Africa indicating those countries where animal infection with Cryptosporidium has been investigated; articles either referenced in Squire and Ryan
(52) or identified by current literature search.
not be analyzed appropriately (80, 81). Thus, lack of reporting
of cryptosporidiosis outbreaks does not necessarily mean they do
not happen. In order to improve our understanding of whether
such outbreaks occur, ensuring the etiology of diarrhea in African
countries is diagnosed and reported is probably the best place
to start, rather than analyzing water samples. Although such
analyses provide clues, the procedures are expensive and result
interpretation may be difficult.
A review (82) identified 60 papers addressingCryptosporidium
in water in Africa. However, from the information presented
it is difficult to extrapolate how many were concerned with
surveillance of drinking water, the analytical methodology used,
and the results obtained. By means of a literature survey of
PubMed (using the search terms of each African country in
turn along with Boolean AND and cryptosporidi∗ AND water)
we identified just 21 papers from Africa (originating from 8
countries) for which drinking water (of different types) had been
analyzed for contamination with Cryptosporidium (see Figure 4
and Supplementary Table 1). Of these, 8 had been published
after the Ahmed et al. (82) review, so would not have been
included there; of the 13 remaining, 5 were cited by Ahmed et al.
(82). Of relevance is that many of these 21 papers used methods
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FIGURE 4 | Map of Africa indicating those countries where contamination of drinking water with Cryptosporidium has been investigated (see
Supplementary Table 1 for further details).
that seem unlikely to provide convincing results (e.g., sample
volumes as low as 10ml, with minimal processing steps, andmZn
for detection of oocysts). Nevertheless, it is these articles that
often provide data indicating the highest proportion of samples
considered positive (over 40%), while papers using standardized
methods for water analysis (those of ISO or US Environmental
Protection Agency) tend to report lower proportions of positive
samples [e.g., the work of Morris et al. from Kenya (83),
Kifleyohannes and Robertson from Ethiopia (84), or Potgjeter
et al. from South Africa (85)]. This suggests that the lack of
specific detection techniques used in other studies may have
resulted in false positive results. In addition, some of the studies
using non-specificmethods report extremely high concentrations
of oocysts (tens or hundreds per liter), which may also indicate
false positives (or excessively high contamination). None of the
studies report subtypes of Cryptosporidium in the water samples,
but 10 reported species, all of whichmentionC. parvum, with one
of these from Egypt also noting the predominance of C. hominis
(86) and one from Kenya reporting 6 samples with C. parvum
and 3 containing C. andersoni (87). In this Kenyan study, the
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samples in which Cryptosporidium was detected were from water
with likely animal contamination, as cattle were watered there
and elephants were known to use it (87). However, the evidence
of animals being the source of the contamination is weak. Among
the other 8 articles in which C. parvum was reported from the
water samples, one [from the same region of Kenya as that
of Muchiri et al. (87)], reports Cryptosporidium in one of 14
samples, with C. parvum detected (88). However, the other 6
articles (published between 1997 and 2019), although reporting
C. parvum, did not apparently undertake any molecular analyses,
and the species definition appears to be based upon supposition
rather than results (Supplementary Table 1).
Two recent articles from the same research project used a
modeling approach to consider Cryptosporidium contamination
of rivers globally (89) and disease burden due to Cryptosporidium
in surface water in sub-Saharan Africa explicitly (90). Worth
noting is that hot spots for river contamination were identified
in Nigeria, Algeria, and South Africa, with human contamination
(point sources) considered to dominate over contamination from
animals (diffuse sources). However, in some African countries
(e.g., DRC, South Sudan, Chad, Ethiopia) more diffuse sources
may predominate, although contamination of river water with
oocysts in these countries was also considered to be amongst the
lowest globally (89). Using not only the modeled contamination
data, but also information on the proportion of population
using surface water as a drinking water supply, along with
drinking water treatments, Limaheluw et al. (90) estimated the
cryptosporidiosis burden due to oocysts in the surface-water
drinking water supply in sub-Saharan Africa to be 1.6 × 106
DALYs. The highest number of DALYs per 100,000 of population
were in Eswatini (1022.8), Mozambique (828.5), and Kenya
(715.2), and the lowest in Senegal (1.3). The extremely high
DALYs in south and south-east Sub-Saharan Africa were partly
explained by higher estimates of life-years lost in people with
HIV/AIDS (90).
RUMINANT LIVESTOCK PRODUCTION IN
AFRICA AND POTENTIAL EFFECTS ON
CRYPTOSPORIDIUM TRANSMISSION
Zoonotic transmission of Cryptosporidium is most likely to
originate from domestic livestock (cattle, sheep, goats), although
other animals, notably rabbits (C. cuniculus) and poultry (C.
meleagridis), may also be important sources. It is therefore
relevant to consider ruminant livestock production systems
in Africa, particularly those in countries with large cattle
populations (91), when considering the potential for zoonotic
transmission of Cryptosporidium. Livestock production systems
vary between and within continents and countries and are
classified on the basis of different criteria and metrics (92).
In Africa, classification of livestock production systems is
complicated by a plethora of factors such as sociocultural, agro-
climate, land use, livestock densities and levels of intensification.
On the basis of agro-climate or how feed for the animals
is produced, Africa is dominated by land-based production
systems, predominantly “mixed, rain-fed” and “grazing” (93).
The pastoral grazing system occurs mainly in arid and semi-
arid areas and the mixed rain-fed system is common in the
humid, semi-humid, and tropical highland areas, but also occurs
in the arid-semiarid climatic zones (94). Grassland utilization
ranges from total nomadism (no permanent place of residence,
no regular cultivation) via semi-nomadism, transhumance, and
partial nomadism, through to stationary animal husbandry (92).
Ruminant livestock production can also be divided by intensity
of production, from extensive to intensive. Extensive production
ranges from small-scale, subsistence production (smallholder
farms) dependent on mixed crop-livestock systems to large
pastoral holdings that rely mainly on rangeland grazing. In
contrast, intensive production system involves geographically-
concentrated and commercially-oriented specialized production
that may develop into industrialization, possibly involving
multinational firms and contract farming (92). Although both
intensive and extensive production of ruminant livestock occurs
in Africa, extensive and pastoral systems tend to predominate. Of
relevance is that calving rate is relatively low (overall about 60%)
and calf mortality relatively high (around 20%) in the majority
of management systems in Africa (94, 95) compared with rates
reported from other countries. Similarly, for small ruminants,
lamb and kid mortality risk is high, although the production rate
is high and prolificacy between 1 and 1.5, lamb and kid mortality
risks are equally high (94). These parameters, in association with
year-round breeding, mean that neonate density tends to be
relatively low in most production systems.
The largest sub-Saharan African livestock populations are in
East Africa with 55.3% of the total livestock units, followed by
West Africa, Southern Africa, and Central Africa, with 27.1, 9.4,
and 8.2%, respectively (94). In arid and semi-arid zones, the
dominant species are goats and sheep followed by cattle, whereas
in sub-humid zones, cattle predominate followed by goats and
sheep with the highest densities of livestock in the highlands
(94). Two countries in East Africa, Ethiopia and Sudan, have
far higher cattle populations than other countries in the region.
An overview table of some relevant key figures regarding cattle
production in some African countries (Burkina Faso, Egypt,
Ethiopia, Kenya, Nigeria, Uganda) is provided (Table 1), in which
the data have been extracted from the series of FAO publications
concerned with livestock production systems (96).
Given the heterogeneous cattle-production systems, the
varying lifestyles of human populations, and the climatic
variability in Africa, the environmental load of Cryptosporidium
oocysts and the risk of human infection from them probably
vary significantly throughout the continent. In arid and semi-
arid environments, where cattle are kept under extensive
management systems in pastoral and agro-pastoral settings, large
numbers of cattle graze together. Although this can potentially
lead to high pasture contamination, it tends to be seasonal
as pastoralists move their animals in search of pasture and
water, and Cryptosporidium oocyst loads are expected only
to be higher where these resources are available (97). In the
pastoral cattle management system, cows with younger calves
remain at home under the management of women and children
on the limited food reserved for them, while other animals
may travel long distances. Whether such division of labor
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TABLE 1 | Relevant comparative data of different cattle-production systems in some African countries.
Country, dairy or beef.
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Breeds: exotic breeds and
crosses of indigenous breeds.
Proportion: 45%
Size: 1–20 animals
Breeds: Mostly crosses and
exotics breeds (42%
Friesian, 25% Bos indicus (Zebu, Sahiwal,
Boran), 18 % Ayrshire, 12%
Guernsey, 3% Jersey)
Proportion: 35%
Size: 1–20 animals Breeds:





Breeds: exotic high-grade dairy
(Friesian, Ayrshires, Fleckvieh,
Guernsey and Jersey
Kenya (beef) Extensive pastoralism Extensive ranching Semi-intensive
(agro-pastoralism)
Intensive (feed lot)
Total: 14.3 million Proportion: 34%
Size: 50 animals
Breeds: indigenous, mainly
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=50–500; medium 50–1,000;




Uganda (beef) Pastoral/mixed smallholder Agro-Pastoral Semi-intensive Commercial ranching
Total: 11.4 million Proportion: 90%
Size: 100–300 animals
Breeds: Mostly local
(Ankole and local zebu)
Proportion: <10%
Size: 10 animals
Breeds: indigenous with some cross breeds
(e.g., East African Zebu and Holstein
Friesian and Ankole and Holstein Friesian
Proportion: <10% Size: 1–5
animals up to 20 Breeds:
crossbreeds of East African





Information derived from: Food and Agriculture Organization of The United Nations (FAO): Africa Sustainable livestock 2050 http://www.fao.org/in-action/asl2050/resources/documents/
livestock-production-systems/en/ (96).
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and animal care among family members increases the risk of
transmission of Cryptosporidium to young children requires
further investigation.
By numbers of livestock, Ethiopia ranks first in Africa.
The cattle production sector here is highly heterogeneous,
comprising both traditional pastoral/agro-pastoral and mixed
crop–livestock production systems and the market-oriented,
intensive and specialized producers. Pastoral/agro-pastoral
production dominates in the Ethiopian lowlands, where livestock
are managed under pasture-based extensive systems. Cattle
dominate the livestock population here, accounting for 25% of
the national herd (Table 1). The mixed crop-livestock system of
Ethiopia carries more than 70% of the cattle population, with
extensive management systems and supplementation from crop
residues [Table 1, (98)]. This system occurs often in densely
populated regions where animals are frequently kept close to
residential areas. Cattle manure here is used as fertilizer and
for fuel as dried dung cakes, mainly prepared by women and
children, potentially resulting in a high risk of exposure to
Cryptosporidium oocysts (and other pathogens) (99).
Specialized commercial dairy systems (exotic and cross
breeds) and feedlot (local zebu) operations in Ethiopia are
concentrated in densely populated urban and peri-urban
settings and constitute a very small fraction of the livestock
population (98). However, in terms of environmental load of
Cryptosporidium oocysts, these operations probably represent
major hot spots in comparison with traditional or extensive
livestock management. Interestingly, Aldeyarbi et al. (51)
mention that most C. parvum infections seem to occur in urban
settings in Africa, where, according to these authors, animals
are not found close to residences. However, as described above,
even in residential areas, people and animals often live in close
proximity and Aldeyarbi et al. (51) may have under-estimated the
extent of such urban-based farming in some areas of Africa.
Dairy cattle production in Kenya is the second largest
contributor to the agricultural GDP and is classified into three
production systems: intensive, semi-intensive, and extensive.
Unlike in Ethiopia, the intensive and semi-intensive dairy
farms predominate in Kenya [Table 1; (100)], whereas all beef
production is by the extensive system. The intensive system is
predominant in theMount Kenya and Central Rift Valley regions,
where crop production is also practiced. It is also common in
many urban and peri-urban centers in humid and sub-humid
areas of the country. In the extensive dairy production system,
3% of farms hold 35% of the dairy cattle population, and 70% of
the national livestock herd is found in Kenya’s arid and semi-arid
lands (100).
In Nigeria there are three dairy cattle production systems:
extensive or traditional, semi-intensive (agro-pastoral), and
intensive (modern) system [Table 1; (101)].Whereas commercial
farms raise imported exotic breeds and their crosses, local breeds
predominate. These are mainly managed by semi-sedentary and
transhumant pastoralists in large herds. However, compared with
herd sizes in North America, these may be considered relatively
small; for example, concentrated animal feeding operations
(CAFOs) predominate in some countries, with more than 70%
of beef produced in the USA in 2002 being derived from CAFOs
holding more than 5000 head of cattle (102). Commercially
oriented, urban cattle farming has started to emerge in Nigeria,
but is still relatively marginal.
As Egypt has limited natural pastures, cattle (and buffalo)
production here is well integrated with cropland. There
are three main production systems: intensive, semi-intensive,
and extensive [Table 1; (103)]. The semi-intensive system is
dominated by improved local breeds, producing both beef and
milk and comprise almost 60% of the total bovine population.
ARE THERE HOT SPOTS FOR ZOONOTIC
TRANSMISSION IN AFRICA?
With the majority of articles from Africa indicating the
predominance of C. hominis in human cases of Cryptosporidium
infection, and asmany livestock infections in Africa are with non-
zoonotic species, such as C. xiaoi, we tried to identify African
studies providing convincing evidence of zoonotic transmission
(“black swan” events). The intention was that such studies may
indicate risk factors for transmission not occurring in other
settings in Africa—given that the overwhelming number of
studies suggest that non-zoonotic transmission predominates.
A review of the literature identified some studies in
which the titles or abstracts indicated that the authors were
considering zoonotic transmission of Cryptosporidium in specific
settings. Most of these studies were based upon investigating
prevalence, sometimes species, and less frequently subtype, of
Cryptosporidium infections in people and animals residing in
similar areas and inferring from these data any potential for
zoonotic transmission [e.g., (104, 105)]. Less frequently case-
control type studies were reported in which the prevalence and
species of Cryptosporidium in people reporting close contact with
animals were compared with prevalence and species in people
reporting little or no contact with animals [e.g., (106)]. However,
the large number of possible confounders and difficulties in
appropriate matching of those with and without animal contact
means the results of such studies are difficult to interpret.
Finally, contact-network analysis, in which samples are analyzed
from both human and animal contacts of people infected
with Cryptosporidium, was reported in two papers (48, 76).
Those studies that have collected the most information (species,
subtype, matched case-control, or contact-network analysis)
are likely to provide the strongest indications regarding the
likelihood of zoonotic transmission. It is therefore interesting
that the two papers providing the most detailed analysis,
with molecular investigation of Cryptosporidium isolates from
humans and animals along with cluster analysis of the results
(48, 76), both suggest that animal-to-human transmission is a
minor, and probably separate, transmission component, although
does occur.
Nevertheless, some studies indicate some likelihood of
zoonotic Cryptosporidium transmission, and it is thus relevant
to consider these more closely. For C. parvum, some articles
from Egypt, Ethiopia, Kenya, Nigeria, São Tomé and Príncipe,
and Tunisia indicate the potential for zoonotic transmission.
These are summarized in Table 2. We considered each article in
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turn, and, based on the information reported, gave a subjective
analysis of the strength of evidence (strong, moderate, or weak)
of zoonotic transmission provided in the situations described.
Thus, articles were only considered where subtype families IIa
or IId were identified. The evidence was considered strong
if similar subtypes were reported from animals and humans
with a plausible connection in time and space, or with other
strong epidemiological and statistical evidence of animal contact
being a risk factor. The evidence was scored as moderate if the
study reported zoonotic species or subtypes from ≥ 3 humans,
plus at least one of the following: detection by at least one
other testing modality (e.g., microscopy), immunocompromised
person, and gastrointestinal symptoms. The additional criteria
were used to increase the probability that detection reflected
infection—either because the symptoms indicated infection or
because of host susceptibility. The additional testing modalities
were also an attempt to exclude molecular detection reflecting
transient passage rather than infection. For articles that presented
neither strong nor moderate evidence, the evidence was classified
as “weak.”
Of the 10 studies identified, only three, two from Egypt,
and one from Tunisia, provided strong evidence that zoonotic
transmission might have occurred. Thus, on the whole, the
majority of articles do not provide convincing evidence of any
“hot spots” of zoonotic transmission, and the overall picture is
that human infections of Cryptosporidium are predominantly
C. hominis and non-IIa/IId C. parvum. Regarding the two
countries (Tunisia and Egypt) where the evidence for zoonotic
transmission was relatively strong, we speculate cautiously that
there are some relevant factors. Both countries are classified
as lower-middle income economies and considered to have a
relatively strong commercial sector and drive for nationally
produced meat and dairy products (113). In addition, due to
geographic and climate factors in both countries, cattle-raising
land is restricted, being basically only available in the northern
areas (specifically the districts of Beja and Bizerte) in Tunisia and
along the Nile and in the Nile delta in Egypt. Thus, by necessity,
there is close integration between cattle raising (both dairy and
beef) and human settlements in both countries. However, with
just a few papers from both countries, it is incorrect to label them
as transmission hot spots, and many other regions also have close
associations between people and cattle raising.
Other articles that indicate zoonotic transmission are
concerned with species other than C. parvum, with some
circumstantial evidence of C. meleagridis, C. muris, C. canis,
C. suis, C. ubiquitum, and C. xiaoi infections in people and
associated animals (see Table 3). As with the C. parvum
articles, these too have been evaluated for the strength of
evidence indicating zoonotic transmission. Interestingly, we were
unable to find any that provided strong evidence of zoonotic
transmission, and probably the strongest indicator that these are
examples of zoonotic transmission are reflected in that these
are typically animal-associated species and that in several of
the studies the infected people are immunocompromised, and
therefore probably likely to be susceptible to pathogens that do
not tend to infect humans. As pointed out in an article that
also discusses the public health threat from zoonotic enteric
protozoa in wildlife (130), the terminologymay be loaded and it is
questionable whether a pathogen should be considered zoonotic
that usually infects only animals and is reported rarely in low
numbers from a highly immunocompromised human patient.
The example given in that article is C. suis, and such pathogens
are described therein as “potentially zoonotic” (130).
THE PREDOMINANCE OF
ANTHROPONOTIC TRANSMISSION OF
CRYPTOSPORIDIUM IN AFRICA: A
REVIEW OF THE EVIDENCE
Summary of Why Zoonotic Transmission
May Be Expected in Africa
Based on the preceding sections of this article, as well as on
previous reviews on Cryptosporidium infections in Africa (51,
52), it is clear that transmission of Cryptosporidium infection of
people in Africa is currently largely anthroponotic (human to
human), being mostly C. hominis or non-zoonotic C. parvum.
However, from a superficial perspective, there are several factors
that would suggest that zoonotic transmission in Africa would be
at least as likely, if not more likely, to occur than in some other
parts of the world. First, the relationships between animals and
their owners in Africa are often much closer than in, for example,
European countries; in Africa, people and their livestock may
literally share the same sleeping quarters. Secondly, there is
probably a greater likelihood of contamination of drinking
water supplies by livestock in Africa than in many parts of the
world, with water supplies often limited, and a general absence
of catchment control for protection of water supplies, with
surface waters used both as drinking water supplies and also
for watering animals (82, 87, 131, 132). Thirdly, animals are
often closely associated with the growth of fruit and vegetables
that are consumed raw—with animals being involved in the
plowing, harvesting, and transport of such crops, and often
standing close by in marketplaces where such crops are sold
(132). Fourthly, in many parts of Africa, there is close contact
between people and animal manure, which is used as a resource
for fertilizer, fuel, and building materials, with the pats often
prepared by hand, frequently by women (also frequently involved
in food preparation) and young children (99, 133). Indeed,
animals in the domestic environment have been cited as being
a contributor to the substantial burden of zoonotic disease,
including cryptosporidiosis (134), either directly or indirectly
(132). Although Aldeyarbi et al. (51) comment that animals are
not found in close proximity to residences in urban settings in
Africa, this seems not to be the case. For example, a survey
from Burkina Faso indicated that more 25% of households in
Ouagadougou kept livestock (135) and in 2019, FAO noted the
potential zoonotic dangers associated with livestock in rapidly
expanding African cities (136).
Thus, with this apparently great potential for zoonotic
transmission in African countries, the question arises about why
it does not seem to occur to a greater extent. We put forward
the following possible reasons, and suggest that all or some of
these may play a role. We also suggest that the large number
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TABLE 2 | Overview of articles for which zoonotic transmission of C. parvum* in Africa is suggested.
Country Evidence of zoonotic transmission provided Evaluation of evidence** References
Egypt Identical subtypes of C. parvum IIa and IId found in stool from
cattle, buffalo and in 7 children (with diarrhea), from the same area
Strong (105)
Egypt Identical subtypes of C. parvum IId found in cattle, buffalo and in 5
humans, in the same area; age and symptoms not reported
Strong (107)
Egypt C. parvum IIa and IId in 2 children with diarrhea in a childcare
center; animal contact reported
Weak/moderate (68)
Ethiopia C. parvum IIa in 9 adults (5 HIV positive) and 3 HIV negative
children, with diarrhea, microscopy positive; various regions;
sampling strategy unclear
Moderate (108)
Ethiopia C. parvum IIa and IId in 71 and 5 adult HIV patients, respectively,
associated with diarrhea and contact with calves
Moderate/strong (65)
Kenya C. parvum IIa in 5 adult HIV patients; 3 with and 2 without diarrhea Moderate (109)
Nigeria C. parvum IIa in 2 healthy children; microscopy positive Weak (64)
São Tomé and Príncipe C. parvum IIa and IId in 2 and 3 pediatric hospital patients,
respectively, microscopy positive; symptoms not specified
Moderate (110)
Tunisia Identical subtypes of C. parvum IIa and IId found in stool from
calves and 4 children (3 with diarrhea), from the same area
Strong (111)
Tunisia C. parvum IIa found in 8 adult patients and IId found in 4 pediatric
and 5 adult patients; symptoms not specified
Moderate (112)
*Only C. parvum gp60 allele families IIa or IId considered in this table (IIc, IIe and IIm gp60 allele types are likely anthroponotic and the evidence for other allele families being zoonotic
is inconclusive).
**Strong: same zoonotic species or subtypes detected in ≥ 1 humans and animals with a plausible connection in time and space, or with other strong epidemiological and statistical
evidence of animal contact being a risk factor.
Moderate: detection of zoonotic species or subtype in ≥3 humans, plus at least one of the following: gastrointestinal symptoms, immunocompromised, detection by ≥1 other
testing modality.
Weak: other detection of zoonotic subtype.
of articles from Africa apparently suggesting the importance of
zoonotic transmission in these settings, may be perpetuating a
misleading myth.
Are C. parvum Infections Relatively
Infrequent in African Livestock?
Our first suggestion is that, C. parvum infection is not well
established among the ruminant livestock populations in many
regions in Africa. Although larger-scale herds do occur in
some parts of Africa, as detailed in the section of this article
on livestock production, livestock rearing is usually extensive,
pastoral, or semi-pastoral. Although there are notable exceptions,
and some large cattle enterprises may be found, in general the
average number of cattle per farm is around 50. A multivariable
analysis of risk factors for pre-weaned calves acquiringC. parvum
infection and C. bovis infection has demonstrated an increased
risk of C. parvum infection with greater herd size, with calves
in herds of over 200 animals being at significantly greater risk
of infection than calves in herds of below 100 animals (137).
Furthermore, with high mortality of neonates and year-round,
relatively low production rates, the neonatal density in African
herds tends to remain low and constant; peaks in zoonotic
transmission at the same time as seasonal lambing and calving
are well recognized in some non-African countries (22, 138).
In addition, other relevant factors that significantly increased
the risk of C. parvum infection in calves was mean monthly
precipitation of 100–150mm (compared with below 100mm),
being housed inside, and the use of hay bedding (137). These
factors are thus those that favor close contact between animals
(herd size and housing) and oocyst survival (hay bedding
and precipitation); the association with hay bedding has also
been reported from a study in Mexico (139). These risk
factors for C. parvum infection in calves are therefore often
lacking in the cattle-husbandry systems predominant in many
African countries, with most herds being below 100 animals.
Furthermore, even in places where large herd sizes may occur
(e.g., in Burkina Faso), these are often being managed in pastoral
systems where other risk factors (e.g., housing and hay bedding)
are lacking (140). Furthermore, in such animal management
systems, exposure to the climate is also likely to be detrimental
to transmission, with desiccation and UV exposure also playing
a part (see the later section on oocyst survival in the African
envirnoment). Indeed, a study from Tanzania (47) in which a
notable lack of Cryptosporidium infection was identified among
601 dairy calves from different management systems, small
herd size and climatic factors were considered to be important
factors that could have reduced the potential for establishment
of infection and/or contributed to disease fade out (141). Similar
arguments may also be proposed for why C. parvum may be less
established in small ruminants in various African countries (142).
Another potential factor of importance for the lack of
infection with C. parvum in African cattle is cattle breed (and,
correspondingly, could also be relevant for small ruminant
livestock). As noted by Chang’a et al. (47), most studies on
Cryptosporidium in cattle involve Bos taurus breeds, but B.
indicus breeds (which often predominate in African farms) may
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TABLE 3 | Overview of articles for which zoonotic transmission of Cryptosporidium species other than C. parvum in Africa is suggested.
Country Evidence of zoonotic transmission provided Evaluation of evidence* References
C. meleagridis
Côte d’Ivoire 9 people with intestinal disorders attending village primary healthcare centers; C.
meleagridis also found in 4 chickens; age or symptoms not further specified
Moderate (57)
Egypt Patients with gastrointestinal symptoms (n = 2) Weak (114)
Equatorial Guinea HIV infected female, also positive by antigen test and microscopy; symptoms not specified Weak (115)
Ethiopia 3 HIV positive children; symptoms not specified Moderate (65)
Gabon 1 child with diarrhea; but no confirmed transmission cluster involving animal contacts
(however, birds not sampled)
Weak (76)
Ghana 3 children with diarrhea; but no confirmed transmission cluster involving animal contacts
(however, birds not sampled)
Moderate (76)
Kenya HIV positive adult patients, 2 with diarrhea, 1 without diarrhea Moderate (108)
Kenya 6 pediatric patients; microscopy positive; symptoms not specified Moderate (116)
Kenya 1 HIV infected patient; microscopy also positive, age or symptoms not specified Weak (117)
Kenya 1 person, no demographic or clinical information Weak (118)
Kenya 1 HIV positive adult; symptoms not specified Weak (119)
Kenya 1 child presenting to hospital; microscopy positive; symptoms not specified Weak (120)
Kenya 2 pediatric patients with diarrhea; microscopy positive Weak (59)
Kenya 1 child with diarrhea; ELISA antigen also positive Weak (121)
Madagascar 5 children with diarrhea and 2 neighboring children of children with Cryptosporidium
diarrhea; but no confirmed transmission cluster involving animal contacts (however, birds
not sampled)
Moderate (76)
Malawi 2 pediatric patients with diarrhea; microscopy positive; rural area Weak (122)
Nigeria 5 asymptomatic children; microscopy positive Moderate (64)
Nigeria HIV-positive adult, asymptomatic; C. meleagridis also detected in 1 chicken from same area Weak (58)
South Africa 1 child hospitalized with diarrhea; gp60 subtype was IIId (found in humans in India, but not
reported in animals)
Weak (123)
South Africa 1 child from a clinic; microscopy positive; symptoms not specified Weak (66)
Tanzania 1 child with diarrhea and 1 neighboring child with Cryptosporidium diarrhea; but no
confirmed transmission cluster involving animal contacts
Weak (76)
Tunisia 3 children without diarrhea; microscopy positive Moderate (110)
Tunisia 2 adult HIV patients, both with gp60 subtype IIIbA26G1R1; 1 immunocompromised child,
not subtyped, in co-infection with C. hominis; symptoms not specified
Moderate (111)
Tunisia 2 children with primary immunodeficiency and diarrhea, one a co-detection with C.
hominis; microscopy positive
Weak (124)
Uganda 3 hospital admitted children with persistent diarrhea Moderate (125)
C. muris
Kenya 1 HIV positive adult with diarrhea; microscopy positive Weak (126)
Kenya 1 child presenting to hospital; microscopy positive; symptoms not specified Weak (120)
Malawi 1 child with diarrhea; co-detection with C. andersoni Weak (122)
Nigeria 1 child with diarrhea; C. muris also detected in 1 goat in same area Weak/moderate (58)
C. felis
Ethiopia 1 HIV positive child; symptoms not specified Weak (65)
Gabon 1 household contact of a child with Cryptosporidium diarrhea Weak (76)
Ghana 2 children with diarrhea; 1 household contact of child with Cryptosporidium diarrhea; 3
neighboring children of children with Cryptosporidium diarrhea; but no confirmed
transmission cluster involving animal contacts
Moderate (76)
Kenya 4 pediatric patients with diarrhea; microscopy positive Moderate (59)
Kenya 2 children presenting to hospital; microscopy positive; symptoms not specified Weak (120)
Nigeria 2 adult HIV patients; symptoms not specified Weak (127)
Nigeria 1 adult HIV patient; symptoms not specified Weak (128)
Tanzania 2 neighboring children of children with Cryptosporidium diarrhea; but no confirmed
transmission cluster involving animal contacts; symptoms not specified
Weak (76)
(Continued)
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TABLE 3 | Continued
Country Evidence of zoonotic transmission provided Evaluation of evidence* References
C. canis
Ethiopia 2 HIV positive children; symptoms not specified Weak (65)
Kenya 3 children presenting to hospital; microscopy positive; symptoms not specified Moderate (120)
Kenya HIV positive adult patients, 2 with diarrhea, 2 without diarrhea Moderate (109)
Kenya 2 pediatric patients; microscopy positive; symptoms not specified Weak (116)
Kenya 1 child with diarrhea; ELISA antigen positive Weak (121)
Nigeria 1 adult HIV patient; symptoms not specified Weak (127)
Nigeria 1 asymptomatic child; microscopy positive Weak (64)
C. suis
Kenya HIV positive adult patients, 1 with diarrhea, 1 without diarrhea Weak (109)
Madagascar 1 adult, no diarrhea; C. suis detected in 3 pigs in the same village Weak (129)
Madagascar 1 child neighbor of a child with Cryptosporidium diarrhea; symptoms not specified; no
confirmed transmission cluster involving animal contacts
Weak (76)
C. ubiquitum








Ethiopia 2 HIV positive children; symptoms not specified Weak (65)
Ghana 1 child with diarrhea (C. xiaoi/bovis); also identified in 19 goats and 5 sheep in the same
region
Weak/moderate (76)
*Strong: same zoonotic species or subtypes detected in ≥ 1 humans and animals with a plausible connection in time and space, or with other strong epidemiological and statistical
evidence of animal contact being a risk factor.
Moderate: detection of zoonotic species or subtype in ≥ 3 humans, plus at least one of the following: gastrointestinal symptoms, immunocompromised, detection by ≥ 1 other
testing modality.
Weak: other detection of zoonotic species or subtype.
be more resistant. A study from Nigeria (143) involving 195
calves of the White Fulani and Sokoto Gudali breeds (both B.
indicus breeds) reported 16% prevalence of Cryptosporidium,
but none were C. parvum. Although systematic investigation
of Cryptosporidium infections in general, and C. parvum in
particular, are lacking, different management routines may be
associated with different breeds [e.g., some breeds of cattle,
particularly European taurine breeds, tend to need to be housed
indoors due to their susceptibility to African trypanosomiasis;
(144)]. A study from Malaysia (145) also supports the
suggestion that particular breeds may be more susceptible to
Cryptosporidium infection, with significantly higher prevalences
of infection reported from Mafriwal cattle (Sahiwal × Friesian
crosses) and from Jersey× Friesian crosses.
In Africa, a study from Zambia (70) considered that the
significantly higher prevalence of Cryptosporidium infection in
dairy-farm cattle compared with beef calves or “traditionally
reared” calves was due to the management factors. These include
higher density of dairy calves favoring propagation of infection
in confined housing, whereas calves in extensively reared beef
and traditional husbandry systems were not only fewer in
number but outside, where any oocysts would be exposed to
environmental pressures such as desiccation and direct sunlight,
resulting in a reduced infection pressure (70). Cattle breed may
also have played a role, as the calves on the dairy farms were
Jersey, Friesian, or crossbreeds, but a mixture of cattle breeds
predominated in the other management systems, including
Brahman and Boran, both B. indicus breeds. Similarly, based on
the results of their study in two relatively large dairy farms in
the central highlands of Ethiopia (49), exotic breeds (Holstein-
Friesian; B. taurus) were suggested as being more vulnerable to
Cryptosporidium infection than the local Zebu breed (B. indicus),
as crossbred calves with a greater proportion of Holstein-Friesian
“blood” had a higher prevalence of Cryptosporidium infection
than calves with a lower proportion. Considering the three
articles that we considered showed relatively strong evidence of
zoonotic transmission of C. parvum, only the one from Egypt
(105) mentions breed; however, although the authors state that,
in general, most livestock in the region of the study were native
crossbreeds, the animal breeds in the study, or in the two
specific farms where zoonotic transmission was suggested, were
not stated.
Thus, although disentangling the potential risk factors from
each other is clearly difficult, it is also apparent that for
various reasons, under current conditions, African cattle may
be generally less likely to be shedding C. parvum oocysts than
cattle elsewhere. However, this does not exclude this parasite
establishing and spreading in African livestock populations as
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circumstances change. Such a scenario could be devastating for
African livestock production, as well as having potential for
disseminating further to people.
Could People in Africa Be Less Susceptible
to Zoonotic Cryptosporidium Infection?
This leads us to explore whether the “other part” of a potential
zoonotic transmission cycle may also exhibit some factors
that contribute to the relative lack of this transmission route;
namely the potential human hosts. Although animal-human
contact is probably more extensive in Africa than in other
areas of the world, there may be some aspects of people in
Africa that result in them having a different probability of
acquiring zoonotic Cryptosporidium infection than elsewhere.
Of particular relevance in this respect is the relatively high
prevalence of infection with C. hominis in young children in
many African countries (5, 25–27); babies and young infants
are generally more likely to be exposed to Cryptosporidium
oocysts from human infections than from animal infections.
Thus, it seems likely that C. hominis infections early in life
may provide some protection against infection with zoonotic
Cryptosporidium species later. Although immune responses to
cryptosporidiosis are currently not completely understood, it
is clear that both innate and adaptive immune responses have
a relevant role in both protection from, and resolution of,
Cryptosporidium infections and cryptosporidiosis. However, the
level of immunity has not been determined, nor the extent
to which there is cross-protection between different species
of Cryptosporidium. An early human experimental study with
C. parvum, in which primary infection of seronegative adults
with a challenge dose was followed by another challenge with
the same C. parvum oocyst isolate approximately 1 year later,
showed that initial exposure may be insufficient to protect against
clinical illness 1 year later (146). However, it is likely that young
children receive several low-level exposures, and this may have
a different outcome to that described in the human-challenge
study. In a later study, adults with pre-existing anti-C. parvum
serum IgG only became infected when challenged with higher
Cryptosporidium oocyst doses, and did not excrete as many
oocysts, indicating that prior exposure toC. parvum does provide
protection from infection and disease at lower oocyst doses (147).
Using another approach to investigate exposure protection,
serological investigations in two UK cities with high and low
incidences of reported cryptosporidiosis indicated that exposure
to non-pathogenic strains of Cryptosporidium or repeated low-
level exposure to pathogenic strains could provide a protective
effect (148). Indeed, it has been suggested that by eliminating
a source of low-level Cryptosporidium oocyst exposure may,
paradoxically, increase the risk of symptomatic infection from
other exposure sources (149).
Regarding evidence of whether exposure to C. hominis
provides cross-immunity against subsequent C. parvum
challenge, analysis of antibody responses in children in Peru
(150) and Bangladesh (151) suggests that C. hominis infection
results in development of notable antibody responses against C.
parvum antigens, indicating that these responses are directed
toward epitopes conserved across species and subtypes. However,
the importance of this is unclear as the roles of B-cells and
antibody responses in cryptosporidiosis remain controversial,
although they do seem to contribute to protection (152). T-cell
mediated responses, particularly with CD4+ type-1-cells, are,
recognized as a more crucial component. An experimental
study using gnotobiotic piglets found that a substantial (one
million oocysts) C. hominis challenge conferred full immunity
against further challenge with the same C. hominis isolate, and
partial immunity (i.e., infected but with significantly lower
oocyst excretion than non-challenged controls) when further
challenged by a substantial (10 million oocysts) C. parvum oocyst
dose (153). Again, these large dose experiments beg the question
regarding whether trickle exposures may be similarly (or more)
likely to provide protection against future challenge, including
with C. parvum or other species.
However, although exposure to Cryptosporidium early in life
may be relevant for limiting future infection (as older children
with responsibility, for example, for herding small ruminants),
including with zoonotic species, other risk factors may occur
in Africa that may increase infection likelihood. These could
include concurrent infections or conditions that may limit the
robustness or effect of an immune response against future
challenge. It is well known that most people living with HIV
reside in Africa, with 25.7 million estimated by World Health
Organization in 2018, compared with 3.8 million in southeast
Asia and 3.5 million in the Americas (154). Cryptosporidiosis is
known as one of the major causes of diarrhea in patients with
HIV, and is associated with significant morbidity and mortality
in the AIDS population; a recent systematic review and meta-
analysis indicated that the pooled prevalence of Cryptosporidium
in HIV-positive patients in Africa was around 11.9% (CI:
8.8%−16.0%) (155), only marginally below that of SE Asia,
which topped the list at 12.7% (CI: 9.7%−16.4%). It is not
surprising that reports on zoonotic Cryptosporidium infections
in Africa with species other than C. parvum are often in people
with immunodeficiencies, particularly from HIV. Of the 51
articles listed in Table 2, 17 refer to infections in people with
immunodeficiencies. It is also clear that other insults to human
health, including malnutrition and other infections that may
occur more commonly in some African countries, may not only
exacerbate symptoms but also contribute toward individuals
being more susceptible to infection due, among other reasons, to
suppressed immunity.
In addition to immune effects of infections and other factors,
genetic variations in the population itself may make individuals,
or populations, more or less susceptible to specific infections. For
cryptosporidiosis, candidate gene studies indicating an increased
risk of cryptosporidiosis include HLA class I and II genes, SNPs
in the mannose binding lectin (MBL) gene, and variation within
the protein kinase C alpha (PRKCA) gene (156). Some of these
variationsmay be of particular relevance to Africans; for example,
it has been noted that the median MBL protein concentration
in blood is considerably lower in Africans than in other racial
groups (157), whereas, in contrast, the “risk” T allele in the
PRKCA gene is reported to occur at relatively low frequencies in
Africa, and least frequently in West Africa (156). Whether these
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genetic variations may affect zoonotic transmission (zoonotic C.
parvum infection) has not yet been explored.
Is the African Environment More
Detrimental to Oocyst Survival?
Finally, the third player in zoonotic transmission of
Cryptosporidium, is the environment. Cryptosporidium
oocysts have long been recognized as being robust to many
environmental pressures (158), and is one reason why
waterborne and foodborne transmission occurs. Some African
environments, with low humidity and high UV index, may
have a negative impact on oocyst survival. Although not all of
Africa is continuously dry and sunny, and there are extremes
of weather and temperature, in general, in several places in
Africa where livestock are grazed, environmental conditions
may not be optimal for prolonged oocyst survival. This reduces
the likelihood of animal-to-animal transmission (see previous
section), and also animal-to-human transmission. Whether
different species or subtypes of Cryptosporidium oocysts may
have greater environmental robustness has been scarcely
investigated, but a tentatively forwarded hypothesis (63) is that
mutation in the COWP9 gene, which as other genes in the
COWP family are associated with oocyst wall formation (159)
may affect robustness, and thus transmission possibilities.
Where water is contaminated with feces of an infected
individual, the potential for oocyst survival, and thus
onward transmission, increases. As animals may have greater
opportunities to contaminate drinking water in Africa than
in other parts of the world, this may argue for an increased
likelihood of zoonotic transmission of Cryptosporidium in
Africa rather than in places where catchment protection
measures are the norm. Indeed, Vermeulen et al. (160) note
that the Cryptosporidium load from manure could be reduced
substantially in several African countries by manure treatment
with elevated temperatures, such as composting. Nevertheless,
data modeling indicates that human, rather than animal, feces
are the more predominant source of oocyst contamination, with
most contamination around growing urban centers, and with the
potential of these urban hot spots to grow and multiply as sewer
connections are installed without corresponding and appropriate
sewage treatment (89).
Contamination of water sources withCryptosporidium oocysts
varies over shorter timesteps than say, monthly averages, with
water contamination likely to respond strongly to major weather
events, such as prolonged and heavy rain or flooding events. It
should be noted that oocysts of animal origin in runoff from
grazing land are more likely to have been already inactivated,
than oocysts from overloaded human sewerage systems that have
spent less time exposed to desiccation and UV radiation. Of
potential relevance in this context, is that even in some countries
where C. parvum tends to be the predominant species associated
with sporadic human infections, C. hominis seems to be the
most usual species associated with waterborne outbreaks. One
example is Sweden, where C. parvum causes most sporadic cases
of cryptosporidiosis [between 2006 and 2008, there was just
under double the number of C. parvum cases compared with
C. hominis cases, with most C. hominis cases infected abroad;
(161)], but major waterborne outbreaks in this country have
been associated with C. hominis [e.g., (162)]. The subtype here
was IbA10G2, which is discussed in greater detail in the section
on species and genotypes. That this subtype occurs rarely in
Africa but is associated with large-scale outbreaks elsewhere,
may suggest that African populations are at risk should it be
introduced; alternatively, should infection with this subtype be
particularly associated with the T allele in the PRKCA gene (156),
then African populations may be partially protected.
CONCLUSIONS
That both zoonotic and anthroponotic transmission of
Cryptosporidium occur has long been accepted, and it is
also well established that these routes are associated with
different Cryptosporidium species and subtypes. However,
in-depth exploration of transmission patterns and what they
mean for public and veterinary health and interventions is
scanty. In our opinion, it is all too common for publications to
quote the serious toll that cryptosporidiosis takes on pediatric
health in countries in Africa (and other low-income areas)
and tie those figures to the potential for zoonotic transmission
of this parasite and the necessity of a One Health perspective
[e.g., (163)]. While we applaud the One Health approach,
such juxtapositions can be misleading for some readers.
Establishment of the facilities for more identification of species
and subtyping of Cryptosporidium in different African countries
in the coming years will provide further data regarding relative
occurrences in different countries, hosts, and situations,
and will be an essential tool for implementing appropriate
control measures. This calls for not only more sophisticated
laboratory infrastructure, but also scientists trained in the various
techniques and with the appropriate skillsets and knowledge for
such investigations.
It is essential that we are aware that in much of Africa,
and probably for a variety of reasons, as discussed in preceding
sections, anthroponotic transmission predominates at present.
We add the words “at present” with emphasis; we want to
stress that the current situation can change and is probably
changing. Globalization may result in introduction of new
species/subtypes of Cryptosporidium; it is common to think
that visitors to Africa from Europe, for example, may return
home with diarrheal pathogens. But it is of equal or greater
importance to think that they may also export specific currently
non-established Cryptosporidium subtypes to Africa, including
C. hominis IbA10G2 and C. parvum IIaA15G2R1. Both of these
are hypothesized to be hypertransmissible (55), but apparently
occur only rarely in Africa currently; if these specific subtypes
are globally hypertransmissible, rather than merely well suited
and established in their current niches, then their introduction
to areas of Africa could be disastrous for both human and
animal health. In addition, changes in farm management
(e.g., less extensive farming, more intensive farming, more
urban farms) may result in animal feces being less exposed
to environmental pressures that inactivate Cryptosporidium
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oocysts and also increase the possibilities of between-cow
transmission, and hence environmental contamination and
infection pressure.
It may be of relevance that the two countries that
seemed to have clearest evidence of zoonotic transmission
of C. parvum (Tunisia and Egypt), and from where subtype
IIaA15G2R1 has been reported, have relatively limited regions
suitable for livestock rearing and thus the potential for
direct or indirect (water contamination) transmission may be
exacerbated by the requirement for high animal densities in a
restricted area.
Although reducing pediatric cryptosporidiosis in Africa, with
its substantial mortality and morbidity burden, should clearly be
a goal, it should also be borne in mind that reduced childhood
immunity may, at population level, result in an epidemiological
shift from an “endemic and predominantly anthroponotic”
toward an “epidemic and predominantly zoonotic” pattern.
Obviously, the negative impact of diarrheal disease is more
damaging in young children, but slightly older children with
acute malnutrition, or children or adults with untreated
HIV, are also vulnerable groups. Although the extent of
waterborne transmission of cryptosporidiosis in Africa is almost
impossible to determine, a water, sanitation, and hygiene
(WASH) perspective is a fundamental concept to limit the
transmission of any diarrheal pathogen, zoonotic or not;
however, WASH initiatives should be “transformative” in order
to have a lasting and substantial impact (164). At the other
end of the technology scale, as genome sequencing studies
uncover relevant mutations, we will gradually gain greater
information that may provide the basis for implementation of
different approaches to limit, or prevent, both anthroponotic and
zoonotic transmission.
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